Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81
Organisation › Details

Jennewein Biotechnologie GmbH

Jennewein Biotechnologie is a leading international industrial biotechnology company with a range of products in the field of human milk oligosaccharides (HMOs) and rare monosaccharides such as L-Fucose and Sialic acid. The company manufactures an extensive portfolio of innovative HMO products, such as 2' fucosyllactose, 3'-fucosyllactose, Lacto-N-neotetraose, and lacto-N-tetraose. These rare sugars are used in the food industry (particularly infant milk formulas), the pharmaceutical industry, and the cosmetic industry. *


Period Start 2005-01-01 established
  Group Chr. Hansen (Group)
Products Industry human milk oligosaccharides (HMO)
  Industry 2 foods, functional
Persons Person Jennewein, Klaus (Jennewein Biotechnologie GmbH 201512 Managing Director + Co-Founder)
  Person 2 Jennewein, Amélie (Jennewein Biotechnologie GmbH Co-Founder)
Region Region Rheinland-Pfalz (town unspecified)
  Country Germany
  Street 32 Maarweg
  City 53619 Rheinbreitbach
  Tel +49-2224-989-4502
    Address record changed: 2017-11-28
Basic data Employees C: 51 to 100 (2020-09-22)
  Currency EUR
  Annual sales 50 (sales, expected (2021) 2021-12-31)
    * Document for �About Section�: Chr. Hansen Holding A/S. (9/22/20). "Press Release: Chr. Hansen Acquires Jennewein Biotechnologie GmbH to Enter and Lead the High-growth Human Milk Oligosaccharides Market".
Record changed: 2020-09-24


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Chr. Hansen (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [iito] Made Without Love 650x80px

» top